Summary.-Pretreatment of rats with isoprenaline sulphate (IPR) stimulated DNA synthesis in both salivary and mammary gland tissues. 
time in rats, but occurred only in IPR-pretreated animals given MNU during the period of IPR-stimulated DNA synthesis. The cumulative index of MNU-induced mammary tumours and the number of tumours per tumour-bearing rat were increased by IPR-pretreatment only if the animals received MNU during the period of IPR-stimulated DNA synthesis.
THE ALKYLATING AGENT MNU is a potent bacterial mutagen (Neale, 1972) .
Although a single i.v. dose of this compound administered to rats induced tumours in a wide variety of organs (Druckrey et al., 1967; Leaver, Swann and Magee, 1969) no MNU-induced salivary gland tumours have been reported. The synthesis of DNA in salivary glands may be stimulated in a synchronous manner by a single injection of the ,-adrenergic drug isoprenaline sulphate, IPR (Barka, 1.965) . Metabolic changes occurring in the salivary glands between time 0 and the synchronized burst of mitosis have been defined, and after a single round of division the tissue becomes quiescent again (Baserga, 1970) . The parotid was the most sensitive salivary gland in this respect and up to 80 % of the cells divided. Previously it had been thought that this effect of IPR was specific to the salivary gland. More recently, hoxvever, IPR-stimulated DNA synthesis has also been observed in rat bladder epithelium (Winter, 1974) and mouse kidney (Malamud and Malt, 1971) . In mice the circadian rhythm of mitotic division is affected by IPR, and thus in kidney, duodenum and corneal epithelium, the observed stimulation or inhibition of DNA synthesis is dependent on the time of injection (Burns, Scheving and Tsai, 1972; Burns and Scheving, 1973) .
DNA synthesis was suggested as the critical factor both in croton oil stimulation of dimethylbenz(a)anthracene (DMBA)-induced murine epidermal tumours (Frei and Harsono, 1967) and in the induction of liver tumours by MNU in partially hepatectomized rats (Craddock and Frei, 1974) . The response of the liver to such an insult is, however, both complex and prolonged (Harkness, 1957) . DNA synthesis was also an important factor in the mutagenic response to MNU by bacteria, in which the number of mutations induced was found to increase with the number of replicating forks on the genome (Hince and Neale, 1975) . If replicating DNA plays an equally important role in mutagenesis and carcinogenesis by MNU, salivary tumours may be expected to occur in MNU-treated animals pretreated with IPR.
MNU is a potent carcinogen, but a single oral dose, given to female Wistar rats of unspecified age, failed to induce mammary tumours, although tumours were observed in a variety of other organs (Leaver et al., 1969) . Huggins, Grand and Brillantes ( 1961) found that the maximum yield of mammary tumours in response to DMBA was obtained by treating female rats 50-65 days old. It was considered that this age group might also provide optimum conditions for induction of mammary tumours by MNU, and consequently, female rats 50-60 days old were used, particular attention being paid to the development of such tumours during the course of the experiment.
The half-life of MNU, after i.v. injection into the rat, is only about 4 min (Swann, 1968 Scott, Fraccastoro and Taft (1956) . The DNA concentration in the final extract was measured by the method of Burton (1956) and a suitable sample withdrawn into 10 ml of Bray's liquid scintillant for estimation of radioactivity.
For the induction of tumours, female Wistar rats, 50 to 60 days old and with body wt., 135-165 g, were divided into groups of 25 animals each. Four groups received injections of IPR, as described above, between 9 a.m. and 10 a.m. so as to minimize any effect of IPR on the circadian rhythm of DNA synthesis (Burns and Scheving, 1973;  Scheving, Burns and Pauly, 1972) . After an interval of 8, 28 or 31 h, 3 of these groups were given 77 mg MNU/kg (LD50 > 90 mg/kg) by i.v. injection. A fifth group received MNU only. The animals were examined each week for palpable mammary tumours and were maintained until death, or killed wlhen obviously near death. At death, all mammary tumours and all salivary glands, except those lost through cannibalism, were retained for histological examination, and macroscopic tumours in other organs were recorded. Statistical comparisons of mammary tumours in each group and the percentages quoted, are based on the cumulative incidence of animals with first palpable tumour, and the significance tests on those were made by the x2 test (following the method of Peto (1974) for non-incidental tumours). In order to prolong survival, palpable mammary tumours appearing before 15 weeks were surgically removed, and 16% of these animals failed to survive the operation for more than 2 weeks. Further mammary tumours arising at sites close to the operation were ignored in the total tumour count, although in no case was there any apparent recurrence of the tumour removed. Statistical comparisons of the incidence of salivarv tumours followed the method of Peto (1974) for incidental tumours.
RESULTS
IPR pretreatment stimulated DNA synthesis, as measured by incorporation of [31H]thymidine, in both salivary and mammary glands. In both tissues, the incorporation of radioactivity remained at a low and relatively constant level for 16 h after IPR treatment (Table I ). The pattern of incorporation of [3H] TdR into salivary glands was similar to that reported by Barka (1965) and Baserga (1970) and showed an increase 20 h after IPR treatment, reaching a peak at 28-30 h which was twelve-fold higher than the initial value. Incorporation of label into Table I ). The variation between samples, and the failure to observe a discrete peak of radioactive incorporation, may have been caused by random distribution of the rats with respect to the stage in the oestrous cycle (Jabara, Toyne and Fisher, 1972) . Among those rats surviving at least 10 weeks after treatment, 5 rats were found to have a total of 6 salivary gland tumours (Table 11 ). All these rats came from those groups given MNU 28 or 31 h after IPR pretreatment. Among the rats surviving at least until the first salivary tumour was observed (25 weeks), there was a significant difference between these two groups and those given MNU 8 h after IPR or given MNU alone (P < 0.05, x2 3-08, 1-tail test).
Five of the tumours were identified as pleomorphic adenomas on histological examination, and one was seen to arise from keratinized squamous epithelium of a salivary gland duct. One of the adenomas came from the sublingual gland and the remainder were probably parotid gland tumours.
Mammary tumours developed within 12 weeks in 170% of surviving rats given MNU only (Table III, Fig. 1 after treatment (Table III) . However, when the carcinogen was administered 28 or 31 h after IPR treatment, similar and significant increases were observed after 12 or 26 weeks in the percentage of tumour-bearing survivors and also in the number of tumours per tumour-bearing survivor (Table III) . The first palpable mammary tumour in control rats given IPR only was not found until 15 months after treatment and, among 12 animals surviving at 19 months, only 4 tumours have appeared.
The first palpable MNU-induced mammary tumour appeared in the eighth week after treatment, and about half the tumours recorded had appeared by 13 weeks (Fig. 1) . Tumour growth was rapid, especially in the rats treated with IPR 28 or 31 h before MNU. More tumours were recoreded in the 6 anterior glands than in the 6 posterior glands. Among other tumours observed macroscopically, kidney tumours were induced in all groups which received MNU. The earliest time for macroscopic observation of kidney tumours was 19 weeks, and they were found frequently in animals dying 30 weeks or longer after treatment (Table  II) . In general the spectrum of tumours was similar to that observed by other authors (Craddock and Frei, 1974; Druckrey et al., 1967; Leaver et al., 1969) . DISCUSSION A single i.v. dose of the unstable carcinogen MNU given at 28 or 31 h after IPR treatment gave rise to the first salivary gland tumours to be observed following MNU administration to rats. No salivary gland tumours were observed in rats given MNU 8 h after IPR treatment or in rats treated with either MNU or IPR alone. The relevance of the IPR pretreatment used here resides in the synchronized burst of DNA synthesis obtained in the salivary glands. Furthermore, by the time of maximum DNA synthesis, other IPR-induced metabolic changes, including increased levels of c AMP and membranebound adenylate cyclase and the stimulation of protein, RNA and glycogen synthesis, have reverted to normal. It has been shown in rats that hormoneinduced stress immediately prior to i.p. injection of radioactive MNU resulted in an increased level of alkylation in liver DNA isolated 30 min later (Magin, O'Connor and Craig, 1975) . Treatment of mammals with IPR does cause a rapid increase in blood flow, however, in the experiments reported here, MNU was administered 8, 28 or 31 h after the IPR injection, i.e. after visible stress had ceased. If there is any residual effect causing an increase in alkylation of DNA by MNU, this should be greatest 8 h after IPR treatment, but no salivary gland tumours were observed in this group. In view of the high level of DNA replication observed in the salivary glands 28 or 31 h after IPR treatment, the number of tumours observed was disappointing, reaching only 13 % of rats surviving 10 weeks or more. Previous induction of salivary tumours by chemical carcinogens has been achieved by placing a pellet, or injection, directly into the gland. The tumour yield varied with these methods, but Gliicksmann and Cherry (1966) obtained carcinomas in 28% of female black-hooded rats injected in the salivary gland complex with an acetone solution of DMBA. A figure of 100% was achieved in the submandibular gland when DMBA was injected directly into this gland (Schmutz and Chaudhry, 1969) . However, whereas the half-life of MNU is a matter of minutes, the exposure to DMBA in the above experiments was prolonged, since DMBA apparently persists at the site of injection for some weeks (Cherry and Gliicksmann, 1965) . Further, a sex difference has been observed in induction of carcinomas by DMBA or adenomas by irradiation: in both cases salivary glands in females were less susceptible than those in males (Glticksmann and Cherry, 1962 Cherry, , 1966 . It is possible that the short carcinogen exposure and the use of female rats may have resulted in the low yield of tumours reported in this paper.
Although a single oral dose of MNU (90 mg/kg body wt.) failed to cause mammary tumours in female Wistar rats (Leaver et al., 1969) the results reported here show that a single i.v. dose of MNU did cause mammary tumours when administered to Wistar rats 50 to 55 days old. The importance of age in the chemical induction of mammary tumours was first noted by Huggins et al., (1961) who obtained 100% incidence in female rats injected with DMBA when 50 to 65 days old, but no mammary tumours if the animals were 105 days old when treated. Several authors using MNU have induced mammary tumours in rats, but in each case the strain differed and multiple doses were administered (Gullino, Pettigrew and Grantham, 1975; Bots and Willighagen, 1975; Hooson, Grasso and Gangolli, 1973) .
In the experiments reported here the time of appearance of the earliest tumour, 7 weeks, and the average latent period for the first tumour to appear, about 12 weeks, were in good agreement with other investigations using MNU (Gullino et al., 1975; Bots and Willighagen, 1975) . In the control group, which received IPR alone, no tumours were observed until 61 weeks after treatment, and it is probable that the final result for this group will be essentially in agreement with the value of 16 600 obtained for spontaneous mammary tumours in 522 female Wistar rats (Nifatov and Koshurnikova, 1973) .
,3-Adrenergic receptors are known to be present in rabbit mammary tissue, and may also be present in rat tissue (Bar, 1973) . Although not so effective as in salivary tissue, nevertheless IPR did stimulate DNA synthesis in mammiary gland tissue during the period 20-39 h after injection. The incidence of MNU-induced mammary tumours was increased by prior administration of IPR, only if the MNU was injected 28 or 31 h after the IPR, during the period of DNA replication. The difference in the number of tumourbearing rats seen between the 31 h group and those receiving IPR 8 h before MNU, or MNU alone, was highly significant at both 12 and 26 weeks post treatment (Table III) . Tumours forming in the 28 or 31 h groups also appeared to grow more rapidly than those induced in other groups. Rats in the 28 and 31 h groups had a higher average number of tumours per animal, and the maximum number of tumours per animal (8) in these groups may be compared with a maximum of 2 in the other groups. Jabara et al. (1972) and Jabara, Wilson and Fisher (1974) failed to correlate changes in DNA synthesis, induced by progesterone or hydroxyurea treatments, with changes in the number of mammary tumours induced by DMBA. The results reported here support the view that increased DNA synthesis in mammary tissue may lead to increased yields of MNU-induced tumours; though it must be remembered that, unlike the well documented salivary gland response, it is not known what other metabolic changes, if any, are induced in mammary tissue by IPR, or if such changes occur during the period of maximum DNA synthesis.
The optimum time for MNU-induction of salivary tumours coincided with the period of IPR-stimulated DNA synthesis, as did the optimum time for induction of mammary tumours. In bacteria, this carcinogen induces mutations preferentially in the region of the chromosome replicating forks (Hince and Neale, 1975) . In both rats (Kleihues, 1969) and bacteria (Neale, 1976 ) MNU inhibits replication of DNA synthesis, and it has been suggested that, in bacteria, this action could play a critical role in induction of proteins involved in accurate or error-prone repair of DNA damage (Neale, 1976) . Nevertheless, it is apparent that the rate of DNA synthesis occurring at the time oftreatment by MNU profoundly affects the biological response of both mammalian and bacterial systems to this compound.
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